Effects of zaprinast and dissolved nitric oxide on the pulmonary circulation of fetal sheep

Pediatric Research

Volumn 39, Issue 2, 1996, Pages 223-228

  Skimming, Jeffrey W ^a   Demarco, Vincent G ^a   Kadowitz, Philip J ^b   Cassin, Sidney ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ALCOHOL; CYCLIC GMP; ENDOTHELIN 1; NITRIC OXIDE; ZAPRINAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FETUS CIRCULATION; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SHEEP;

EID: 0030040443     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199602000-00006     Document Type: Article

References (45)

1. Enhörning G, Adams FH, Norman A 1966 Effect of lung expansion on fetal lamb circulation. Acta Paediatr Scand 55:441-451
2. Reynolds SR 1956 The fetal and neonatal pulmonary vasculature in the guinea pig in relation to hemodynamic changes at birth. Am J Anat 98:97-127
3. Cook CD, Drinker PA, Jacobson HN, Levinson H, Strang LB 1963 Control of pulmonary blood flow in the foetal and newly born lamb. J Physiol 169:10-29
4. Lauer RM, Evans JA, Aoki H, Kittle CF 1965 Factors controlling pulmonary vascular resistance in fetal lambs. J Pediatr 67:568-577
5. Cassin S 1981 Prostaglandins and the perinatal pulmonary circulation. In: Mehta J, Mehta P (eds) Platelets and Prostaglandins in Cardiovascular Disease. Futura Publishing, New York, pp 219-249
6. Leffler CW, Hessler JR, Green RS 1984 The onset of breathing at birth stimulates pulmonary vascular prostacyclin synthesis. Pediatr Res 18:938-942
7. Davidson D 1988 Pulmonary hemodynamics at birth: effect of acute cyclooxygenase inhibition in lambs. J Appl Physiol 64:1676-1682
8. Griffith TM, Edwards DH, Lewis MJ, Henderson AH 1985 Evidence that cyclic guanosine monophosphate (cGMP) mediates endothelium-dependent relaxation. Eur J Pharmacol 112:195-202
9. Waldman SA, Murad F 1988 Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system. J Cardiovasc Pharmacol 12(suppl 5):S115-S1I8
10. Arnold WP, Mittal CK, Katsuki S, Murad F 1977 Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 74:3203-3207
11. Ignarro LJ, Kadowitz PJ 1985 The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25:171-191
12. Holzman S 1982 Endothelium-induced relaxation by acetylcholine associated with larger rises in cyclic GMP in coronary arterial strips. J Cyclic Nucleotide Res 8:409-419
13. Martin W, Furchgott RF, Villani GM, Jothianandan D 1986 Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J Pharmacol Exp Ther 237:539-547
14. Souness JE, Brazdil R, Diocee BK, Jordan R 1989 Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine. Br J Pharmacol 98:725-734
15. Hidaka H, Tanaka T, Itoh H 1984 Selective inhibitors of three forms of cyclic nucleotide phosphodiesterases. Trends Pharmacol Sci 5:237-239
16. Braner DAV, Fineman JR, Chang R, Soifer SJ 1993 M&B 22948, a cGMP phosphodiesterase inhibitor is a pulmonary vasodilator in lambs. Am J Physiol 264:H252-H258
17. McMahon TJ, Ignarro LJ, Kadowitz PJ 1993 Influence of Zaprinast on vascular tone and vasodilator responses in the cat pulmonary vascular bed. J Appl Physiol 74:1704-1711
18. Trapani AJ, Smits GJ, McGraw DE, McMahon EG, Blaine EH 1991 Hemodynamic basis for the depressor activity of zaprinast, a selective cGMP phosphodiesterase inhibitor. J Pharmacol Exp Ther 258:269-274
19. Kukovetz WR, Holzmann S, Wurm A, Poch G 1979 Evidence for cyclic GMP-mediated relaxant eifects of nitro-compounds in coronary smooth muscle. Naunyn-Schmiedebergs Arch Pharmacol 310:129-138
20. Tiktinsky MH, Morin FC 1993 Increasing oxygen tension dilates fetal pulmonary circulation via endothelium-derived relaxing factor. Am J Physiol 265:H376-H380
21. McQueston JA, Cornfield DN, McMurtry IF, Abman SH 1993 Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation. Am J Physiol 264:H865-H871
22. Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IF 1991 Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am J Physiol 260:L280-L285
23. + channel pulmonary vasodilation in fetal lambs: role of endothelium-derived nitric oxide. J Appl Physiol 73:188-194
24. Shaul PW, Farrar MA, Zellers TM 1992 Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 262:H355-H364
25. Abman SH, Accurso FJ 1991 Sustained fetal pulmonary vasodilation with prolonged atrial natriuretic factor and GMP infusions. Am J Physiol 260:H183-H192
26. Feelisch M 1991 The biochemical pathways of nitric oxide formation from nitro vasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol 17(suppl 3):S25-S33
27. ω-nitro-L-arginine in fetal lambs. J Appl Physiol 72:1730-1734
28. Chakder S, Rattan S 1993 Involvement of cAMP and cGMP in relaxation of internal anal sphincter by neural stimulation, VIP, and NO. Am J Physiol 264:G702-G707
29. Maurice DH, Haslam RJ 1990 Nitroprusside enhances isoprenaline-induced increases in cAMP in rat aorta smooth muscle. Eur J Pharmacol 191:471-475
30. Maurice DH, Haslam RJ 1990 Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cAMP breakdown by cGMP. Mol Pharmacol 37:671-681
31. + channel of vascular smooth muscle cells. FEBS Lett 345:47-49
32. Tare M, Parkington HC, Coleman HA, Neild TO, Dusting GJ 1990 Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium. Nature 346:69-71
33. Krippeit-Drews P, Morel N, and Godfraind T 1992 Effect of nitric oxide on membrane potential and contraction of rat aorta. J Cardiovasc Pharmacol 20(suppl 12):S72-S75
34. + channels in vascular smooth muscle cells. Proc Natl Acad Sci USA 85:9360-9364
35. 2+-activated K channels and contraction of cultured smooth muscle cells of porcine coronary artery. J Pharmacol Exp Ther 256:371-377
36. Itoh Y, Suzuki H, and Kuriyama H 1978 Effects of sodium nitroprusside on smooth muscle cells of rabbit pulmonary artery and portal vein. J Pharmacol Exp Ther 207:1022-1031
37. Cheung DW, MacKay MJ 1985 The effects of sodium nitroprusside and 8-bromocyclic GMP on electrical and mechanical activities of the rat tail artery. Br J Pharmacol 86:117-124
38. Itoh Y, Kitamura K, and Kuriyama H 1978 Actions of nitroglycerine on the membrane and mechanical properties of smooth muscles of the coronary artery of the pig. Br J Pharmacol 70:197-204
39. Brayden JE, Large WA 1986 Electrophysiological analysis of neurogenic vasodilatation in the isolated lingual artery of the rabbit. Br J Pharmacol 89:163-171
40. Kitamura K, Kuriyami H 1979 Effects of acetylcholine on the smooth muscle of isolated main coronary artery of the guinea-pig. J Physiol 293:119-133
41. Lippton HL, Cohen GA, McMurtry IF, Hyman AL 1991 Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J Appl Physiol 70:947-952
42. Hasunuma K, Rodman DM, O'Brien RF, McMurtry IF 1990 Endothelin 1 causes pulmonary vasodilation in rats. Am J Physiol 259:H48-H54
43. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA 1994 Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368:850-853
44. 3. Biochim Biophys Acta 234:493-498
45. Cleeter MW, Cooper JM, Darly-Usmar VM, Moncada S, Schapira AH 1994 Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases. FEBS Lett 345:50-54